Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Ikeda

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Pharmacokinetics|December 24, 2010
Drug-induced idiosyncratic hepatotoxicity: prevention strategy developed after the troglitazone caseToshihiko Ikeda
Chudoku Kenkyu : Chudoku Kenkyukai Jun Kikanshi = the Japanese Journal of Toxicology|May 10, 2012
[Idiosyncratic drug toxicity]Toshihiko Ikeda
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2015
[Recent findings regarding the mechanism of idiosyncratic drug toxicity]Toshihiko Ikeda
Drug Metabolism and Pharmacokinetics|May 15, 2007
SNP communications: coalition of toxicology and drug metabolism and pharmacokineticsToshihiko Ikeda
Current Medicinal Chemistry|September 24, 2014
Idiosyncratic drug hepatotoxicity: strategy for prevention and proposed mechanismToshihiko Ikeda
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 2, 2006
[Drug-induced liver injury]Toshihiko Ikeda
Drug Metabolism and Pharmacokinetics|September 6, 2005
Repeated glucuronidation at one hydroxyl group leads to structurally novel diglucuronides of steroid sex hormonesTakahiro Murai, Haruo Iwabuchi, Toshihiko Ikeda
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 6, 2006
Human UDP-glucuronosyltransferase, UGT1A8, glucuronidates dihydrotestosterone to a monoglucuronide and further to a structurally novel diglucuronideTakahiro Murai, Naozumi Samata, Haruo Iwabuchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2012
Glutaredoxin is involved in the formation of the pharmacologically active metabolite of clopidogrel from its GSH conjugateKatsunobu Hagihara, Miho Kazui, Atsushi Kurihara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 2, 2010
Glutaredoxin and thioredoxin can be involved in producing the pharmacologically active metabolite of a thienopyridine antiplatelet agent, prasugrelKatsunobu Hagihara, Miho Kazui, Atsushi Kurihara, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Pharmacokinetics|December 24, 2010
Drug-induced idiosyncratic hepatotoxicity: prevention strategy developed after the troglitazone caseToshihiko Ikeda
Chudoku Kenkyu : Chudoku Kenkyukai Jun Kikanshi = the Japanese Journal of Toxicology|May 10, 2012
[Idiosyncratic drug toxicity]Toshihiko Ikeda
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2015
[Recent findings regarding the mechanism of idiosyncratic drug toxicity]Toshihiko Ikeda
Drug Metabolism and Pharmacokinetics|May 15, 2007
SNP communications: coalition of toxicology and drug metabolism and pharmacokineticsToshihiko Ikeda
Current Medicinal Chemistry|September 24, 2014
Idiosyncratic drug hepatotoxicity: strategy for prevention and proposed mechanismToshihiko Ikeda
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 2, 2006
[Drug-induced liver injury]Toshihiko Ikeda
Drug Metabolism and Pharmacokinetics|September 6, 2005
Repeated glucuronidation at one hydroxyl group leads to structurally novel diglucuronides of steroid sex hormonesTakahiro Murai, Haruo Iwabuchi, Toshihiko Ikeda
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 6, 2006
Human UDP-glucuronosyltransferase, UGT1A8, glucuronidates dihydrotestosterone to a monoglucuronide and further to a structurally novel diglucuronideTakahiro Murai, Naozumi Samata, Haruo Iwabuchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2012
Glutaredoxin is involved in the formation of the pharmacologically active metabolite of clopidogrel from its GSH conjugateKatsunobu Hagihara, Miho Kazui, Atsushi Kurihara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 2, 2010
Glutaredoxin and thioredoxin can be involved in producing the pharmacologically active metabolite of a thienopyridine antiplatelet agent, prasugrelKatsunobu Hagihara, Miho Kazui, Atsushi Kurihara, et al.
Pageof 6